Physician profile
David A Levine
NPI 1265887079
$3,152.81
in general payments reported to CMS, 2019-2025
16 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $16.53 · 2021: $135 · 2022: $558 · 2023: $851 · 2024: $1,130 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,338.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $829.92 | 2022-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $398.90 | 2023-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $283.84 | 2023-2025 | Syfovre |
| Abbvie INC. | $279.63 | 2022-2025 | |
| Alcon Vision LLC | $240.09 | 2019-2021 | |
| Dutch Ophthalmic, USA | $174.11 | 2023 | Eva, Combined Machine, Tissueblue |
| Alimera Sciences, INC. | $164.58 | 2024 | Iluvien, Yutiq |
| Eyepoint US, INC. | $159.44 | 2022 | |
| Genentech USA, INC. | $131.77 | 2023-2024 | Vabysmo |
| Coherus Oncology, INC. | $125.00 | 2023 | |
| Rayner Intraocular Lenses Limited | $124.99 | 2024 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Mallinckrodt Hospital Products INC. | $98.48 | 2024 | Acthar |
| Mylan Specialty L.P. | $74.56 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.67 | 2022-2023 | Jublia |
| Ani Pharmaceuticals, INC. | $23.30 | 2025 | Yutiq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $16.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.